SPDR S&P Biotech ETF (NYSEARCA:XBI) Sets New 1-Year High – Here’s What Happened

SPDR S&P Biotech ETF (NYSEARCA:XBI) reached a new 52-week high during trading on Tuesday . The stock traded as high as $133.60 and last traded at $132.05, with a volume of 7846720 shares changing hands. The stock had previously closed at $129.44.

SPDR S&P Biotech ETF Stock Performance

The company has a market cap of $8.79 billion, a price-to-earnings ratio of 11.47 and a beta of 0.88. The firm has a fifty day moving average price of $125.79 and a 200 day moving average price of $120.36.

Institutional Investors Weigh In On SPDR S&P Biotech ETF

Several hedge funds have recently added to or reduced their stakes in the business. Dynamic Wealth Strategies LLC raised its position in shares of SPDR S&P Biotech ETF by 3.8% during the fourth quarter. Dynamic Wealth Strategies LLC now owns 2,201 shares of the exchange traded fund’s stock worth $268,000 after purchasing an additional 80 shares during the period. Capital Investment Advisory Services LLC raised its position in shares of SPDR S&P Biotech ETF by 4.0% during the fourth quarter. Capital Investment Advisory Services LLC now owns 2,123 shares of the exchange traded fund’s stock worth $259,000 after purchasing an additional 81 shares during the period. Commerce Bank raised its position in shares of SPDR S&P Biotech ETF by 2.8% during the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock worth $397,000 after purchasing an additional 90 shares during the period. Compass Ion Advisors LLC grew its holdings in SPDR S&P Biotech ETF by 2.6% during the fourth quarter. Compass Ion Advisors LLC now owns 3,886 shares of the exchange traded fund’s stock worth $474,000 after buying an additional 97 shares in the last quarter. Finally, AdvisorNet Financial Inc grew its holdings in SPDR S&P Biotech ETF by 7.3% during the third quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after buying an additional 100 shares in the last quarter.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.